99 related articles for article (PubMed ID: 11306790)
1. Bacterial adhesiveness: effects of the SH metabolite of erdosteine (mucoactive drug) plus clarithromycin versus clarithromycin alone.
Braga PC; Zuccotti T; Dal Sasso M
Chemotherapy; 2001; 47(3):208-14. PubMed ID: 11306790
[TBL] [Abstract][Full Text] [Related]
2. The combination of the SH metabolite of erdosteine (a mucoactive drug) and ciprofloxacin increases the inhibition of bacterial adhesiveness achieved by ciprofloxacin alone.
Dal SM; Bovio C; Culici M; Braga PC
Drugs Exp Clin Res; 2002; 28(2-3):75-82. PubMed ID: 12224380
[TBL] [Abstract][Full Text] [Related]
3. Effects of erdosteine and its metabolites on bacterial adhesiveness.
Braga PC; Dal Sasso M; Sala MT; Gianelle V
Arzneimittelforschung; 1999 Apr; 49(4):344-50. PubMed ID: 10337454
[TBL] [Abstract][Full Text] [Related]
4. Sub-lethal concentrations of clarithromycin interfere with the expression of Staphylococcus aureus adhesiveness to human cells.
Braga PC; Piatti G
J Chemother; 1993 Jun; 5(3):159-63. PubMed ID: 8371124
[TBL] [Abstract][Full Text] [Related]
5. The SH-metabolite I of erdosteine, a mucolytic drug, enhances the inhibitory effect of salbutamol on the respiratory burst of neutrophils.
Dal Sasso M; Bovio C; Culici M; Fonti E; Braga PC
Drugs Exp Clin Res; 2002; 28(4):147-54. PubMed ID: 12512232
[TBL] [Abstract][Full Text] [Related]
6. A combination of budesonide and the SH-metabolite I of erdosteine acts synergistically in reducing chemiluminescence during human neutrophil respiratory burst.
Dal Sasso M; Culici M; Guffanti EE; Bianchi T; Fonti E; Braga PC
Pharmacology; 2005 Jun; 74(3):127-34. PubMed ID: 15753624
[TBL] [Abstract][Full Text] [Related]
7. Effects of subinhibitory concentrations of seven macrolides and four fluoroquinolones on adhesion of Staphylococcus aureus to human mucosal cells.
Braga PC
Chemotherapy; 1994; 40(5):304-10. PubMed ID: 7956453
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of metabolite I of erdosteine on the generation of nitric oxide and peroxynitrite chemiluminescence by human neutrophils.
Dal Sasso M; Culici M; Bianchi T; Fonti E; Braga PC
Pharmacology; 2004 Jul; 71(3):120-7. PubMed ID: 15161993
[TBL] [Abstract][Full Text] [Related]
9. Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent.
Cazzola M; Page C; Rogliani P; Calzetta L; Matera MG
Drugs; 2020 Nov; 80(17):1799-1809. PubMed ID: 33025535
[TBL] [Abstract][Full Text] [Related]
10. A time-kill evaluation of clarithromycin and azithromycin against two extracellular pathogens and the development of resistance.
Burgess DS; Hastings RW; Horan JL
Ann Pharmacother; 1999 Dec; 33(12):1262-5. PubMed ID: 10630825
[TBL] [Abstract][Full Text] [Related]
11. Clarithromycin inhibits rhinovirus-induced bacterial adhesions to nasal epithelial cells.
Wang JH; Lee SH; Kwon HJ; Jang YJ
Laryngoscope; 2010 Jan; 120(1):193-9. PubMed ID: 19877190
[TBL] [Abstract][Full Text] [Related]
12. Protective role of erdosteine on vancomycin-induced oxidative stress in rat liver.
Sahin M; Cam H; Olgar S; Tunc SE; Arslan C; Uz E; Yilmaz HR
Mol Cell Biochem; 2006 Oct; 291(1-2):155-60. PubMed ID: 16733804
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the antioxidant activity of the SH metabolite I of erdosteine on human neutrophil oxidative bursts.
Braga PC; Dal Sasso M; Zuccotti T
Arzneimittelforschung; 2000 Aug; 50(8):739-46. PubMed ID: 10994158
[TBL] [Abstract][Full Text] [Related]
14. Erdosteine: antitussive and anti-inflammatory effects.
Dal Negro RW
Lung; 2008; 186 Suppl 1():S70-3. PubMed ID: 18185958
[TBL] [Abstract][Full Text] [Related]
15. Effect of sub-inhibitory concentrations of clarithromycin and erythromycin on the production of Staphylococcus aureus capsules.
Ohtomo T; Ohshima Y; Usui Y; Ichiman Y; Yanagisawa N; Yokota E; Shimada J
J Chemother; 1995 Nov; 7 Suppl 4():9-11. PubMed ID: 8904089
[No Abstract] [Full Text] [Related]
16. Effects of subinhibitory concentrations of pefloxacin on the adherence of Staphylococcus aureus to human cells.
Desnottes JF; Diallo N; Moret G; Santonja R
Drugs Exp Clin Res; 1987; 13(2):69-73. PubMed ID: 3472868
[TBL] [Abstract][Full Text] [Related]
17. The effect of erdosteine on airway defence mechanisms and inflammatory cytokines in the settings of allergic inflammation.
Fraňová S; Kazimierová I; Pappová L; Molitorisová M; Jošková M; Šutovská M
Pulm Pharmacol Ther; 2019 Feb; 54():60-67. PubMed ID: 30502381
[TBL] [Abstract][Full Text] [Related]
18. Erdosteine: Drug exhibiting polypharmacy for the treatment of respiratory diseases.
Dal Negro R; Pozzi E; Cella SG
Pulm Pharmacol Ther; 2018 Dec; 53():80-85. PubMed ID: 30352285
[TBL] [Abstract][Full Text] [Related]
19. Erdosteine enhances mucociliary clearance in rats with and without airway inflammation.
Hosoe H; Kaise T; Ohmori K
J Pharmacol Toxicol Methods; 1998 Oct; 40(3):165-71. PubMed ID: 10334633
[TBL] [Abstract][Full Text] [Related]
20. The effect of erdosteine and its active metabolite on reactive oxygen species production by inflammatory cells.
Miyake K; Kaise T; Hosoe H; Akuta K; Manabe H; Ohmori K
Inflamm Res; 1999 Apr; 48(4):205-9. PubMed ID: 10344471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
